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Abstract.  The mode of transport of ceruloplasmin 
(CP) into the liver was investigated in fractionated 
liver cell suspensions. Incubation of '25I-CP at 4"C 
with these different fractions led to its binding only to 
endothelial cells but not Kupffer cells and hepato- 
cytes. Incubation at 37"C led to rapid uptake of 125I- 
CP by endothelium, but cell-associated radioactivity 
declined after 15 min, which suggests the release of 
the labeled substance. Internalization  was confirmed 
by fractionation of surface-bound and internalized li- 
gand. The released label now acquired binding poten- 
tial for fresh target hepatocytes, and the binding was 
inhibitable with asialoceruloplasmin but not native 
CP. This suggested that the released molecule was 
modified in the endothelium by desialation. Desiala- 
tion was confirmed by incubation of endothelium 
with double-labeled CP (3H label on sialic acid and 
125I on the protein part). We conclude that in the 
liver, CP is first recognized and taken up by endothe- 
lial cells that are endowed with appropriate surface 
receptors for the protein. Endothelium then modifies 
the molecule by desialation to expose the penultimate 
galactosyl residues. The modified molecule is then re- 
leased, recognized, and taken up by hepatocytes 
through their membrane galactosyl-recognition sys- 
tem. These findings are consistent with the role of 
endothelium as an active mediator of molecular trans- 
port between blood and tissue, and further assign a 
biological role for the galactosyl-recognition system in 
hepatocytes. 
H 
EPATOCYTE membrane contains a well-characterized 
receptor that can bind galactosyl residues of glyco- 
proteins  (2,  12). Thus,  while native  ceruloplasmin 
(CP) ~  is cleared from the circulation with a half-life of 2-3 d 
(1), the clearance rate is remarkably enhanced by desialation, 
which exposes its penultimate  galactose residues (2, 14). The 
functional  significance  of these  galactosyl  receptors  is  not 
well-studied. Moreover, the mode of CP transport  from the 
circulation into the liver is not exactly known. 
We have recently developed a visual probe by covalently 
coupling various proteins to submicron sized amide-modified 
latex  particles  (minibeads)  (24). This  probe  permits  topo- 
graphic  observations  and  semiquantitation  of receptors  on 
individual  cells in scanning electron  microscopy (SEM). In- 
ternalization  of the probe could also be visualized by trans- 
mission electron microscopy (TEM). When this method was 
applied to study the uptake of CP by liver cell suspensions 
(8), the binding was found to be entirely limited to endothelial 
cells. Neither hepatocytes nor Kuppfer cells bound the probe. 
In the present study, we provide evidence to suggest that, 
in the liver, native CP is first recognized and removed by the 
endothelium  and is then released (diacytosis or transcytosis 
[28]). In the course  of its endothelial  passage, CP may be 
modified by desialation, a process that can expose its penul- 
Abbreviations used in this paper: ASCP, asialoceruloplasmin; CP, ceruloplas- 
min;  SEM, scanning  electron  microscopy; TCA, trichloroacetic  acid; TEM, 
transmission electron microscopy. 
timate galactosyl residues making it recognizable to hepato- 
cytes. Suggestive evidence is also presented  to indicate  that 
the molecule, so released, may indeed be taken  up by hepa- 
tocytes. Thus, liver endothelium  may mediate the uptake of 
CP by hepatocytes. 
Materials and Methods 
Materials 
CP (Sigma Chemical Co., St. Louis, MO) was purified in our laboratory on a 
Sephadex G-200 column and its purity was then demonstrated  by polyacryl- 
amide gel electrophoresis (PAGE). Lyophilized metrizamide  (grade  1), colla- 
genase type IV, bovine serum albumin  (fraction V powder, BSA), and neura- 
minidase  from Clostridium perfringens attached  to beaded agarose were also 
obtained from Sigma Chemical Co. Carrier-free Na ~2sI, NaB3H4, and Bolton- 
Hunter reagent were obtained  from ICN Pharmaceuticals,  Inc. (lrvine, CA) 
and immobilized lactoperoxidase from Worthington Biochemical Corp. (Free- 
hold, N  J). 
Fractionation of  Liver Cell Suspensions 
Liver cell suspensions were prepared from male Sprague-Dawley rats (200-250 
g) by a collagenase perfusion method  that has been described in detail (8,  18, 
19). Fractionation of  these suspensions was done first on metrizamide gradients 
by a modified method  of Seglen (18), also described previously in detail (19). 
This fractionation  yielded two cellular  fractions, one that  consisted of 99% 
hepatocytes (identified in SEM and TEM by counting  1,000 cells) and only 1% 
nonparenchymal  cells with a viability of >90% (Table 1). The second fraction, 
which consisted of 99% nonparenchymal  cells (Kupffer and endothelial cells), 
was further fractionated by centrifugal elutriation. 
Cells were suspended in phosphate-buffered saline (PBS), and loaded in a 
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Fractionated Liver Cell Suspensions Used in This Study 
Purity*  Viability 
Hepatocytes  ~99%  ->99% 
Kupffer cells  95-99%  ->99% 
Endothelial cells  ->90%  ->97% 
* Cell  identification  was  made  by counting  1,000 cells in  SEM  and  TEM 
preparations  (see the text). 
Beckman JE6-B standard elutrialor rotor (4.2 ml) using a J2-21 centrifuge (30). 
Before cell loading, the rotor was eluted with PBS at a flow rate of 11 ml/min. 
The rotor was then loaded with the cell suspension in PBS at a concentration 
of 107/ml using a total volume of no more than 5 ml, maintaining  the same 
flow rate. After the cell loading, elutriation was carried out at 750 g (2,500 rpm) 
at 20"C. The flow rate was increased to 20 ml/min, and 250 ml of eluant fluid 
was collected. This fraction contained  95-99% endothelium  (Table 1) as deter- 
mined by examination  of 1,000 cells (for each differential cell count) in SEM 
and TEM where endothelial  cells have characteristic surface and cytoplasmic 
features  (19). This  was further confirmed  by  the  reaction  with  factor  VIII 
antibody (using an indirect method [23]). The viability was ~99%. The second 
fraction was obtained at the flow rate of 42 ml/min. This fraction consisted of 
>90% (Table I) Kupffer cells as identified by SEM and TEM. The contaminant 
was mostly  endothelial  cells but also a  few bile epithelial cells. Viability of 
recovered cells was above 97%. 
Radioisotope Labeling Methods 
Iodination  of CP was done by the lactoperoxidase method as described (4, 8). 
The final specific activity of the labeled protein was 0.25 mCi/mg. CP was also 
double-labeled  with  3H  (sialic acid  residues)  and  ~2~1 (protein  moiety)  as 
described elsewhere ( 11 ). aH labeling was done by the consecutive oxidation- 
reduction method of Van Lenten and Ashwell (27). CP ( 1 mg/ml) was dissolved 
in  0.1  M  sodium  acetate  that  contained  0.15 M  NaCI (pH  5.6). This  was 
oxidized by incubation  with 0.24  ml of 0.012 M NalO4 for  10 min at 0*C. 
Oxidation was stopped by the addition of  excess ethylene glycol (l ml), and the 
solution  was dialyzed overnight  at 4"C against  PBS, pH 7.4. Periodate  con- 
sumption, determined  by the method of Dyer (5), indicated more than 1.8 tool 
of periodate consumed per mole of sialic acid, remarkably close to 2 moI per 
mole which is theoretically ideal. Tritium was then introduced  into sialic acid 
residues by adding  0.1  mg tritiated  NaBH4 dissolved in 0.02  ml  of 0.01  M 
NaOH. After mixing, the solution was warmed to room temperature,  and the 
reduction  was allowed to continue  for 30  min with  stirring. To ensure  the 
completeness of reduction, 0.3 nag of nonradioactive KBH4 was added and the 
incubation was continued for another 30 min. Excess borohydride was removed 
by dialysis against 0.1  M Na acetate and 0.15 M NaCI (pH  5.6) for several 
hours before exhaustive dialysis against PBS (pH 7.4). Subsequently hydrolysis 
of the sialic acid (27) by either sulfuric acid or enzymatic method (neuramini- 
dase) demonstrated  that,  respectively, 99.5% or 98.7% of the label was sialic 
acid. 
This tritiated CP was then iodinated by using the Bolton-Hunter  reagent (3) 
since the usual  peroxidation  method could  remove  the 3H  label from  sialic 
acid. To obtain maximum labeling, tritiated CP was dialyzed overnight against 
0.1  M  borate  buffer (pH 8.5) and to this  solution  1 mCi of Bolton-Hunter 
reagent in 0.1  M borate  buffer was added  and incubated  for 15  min at 0*C. 
Unused reagent was reacted with 0.5 ml of  0.2 M glycine in 0. I M borate buffer 
for  15  min at  0°C. The preparation  was passed through a  G-25  Sephadex 
column  (0.7  ×  10  cm) to  remove  glycine and  unattached  Bolton-Hunter 
reagent. The final specific activities of 3H and '251 were 0.12 mCi and 0.11 mCi 
per milligram of protein. 
Removal of Sialic Acid 
CP  was desialated  by  incubating  10  mg/ml of the  protein  with  0.5  ug  of 
neuraminidase  attached  to  beaded  agarose  (29) in  a  buffer  (pH  5.5) that 
contained  0.1 M sodium acetate with 5 mM calcium chloride for 24 h at room 
temperature  in  a  mechanical  shaker.  Neuraminidase  was then  removed  by 
centrifugation. Asialoceruloplasmin (ASCP) was separated from free sialic acid 
by passing through the column of Sephadex G-25 (2 ×  25 cm). The removal 
of sialic acid  was confirmed  by  the  thiobarbituric  acid  method  (26)  and 
calculation  indicated  that  more than  90%  of the sialic acid content  of the 
molecule was removed. 
Incubations 
Incubations  were done in microcentrifuge tubes. Suspensions of endothelium 
or  hepatocyte  fractions  (1  x  106  cells/tube)  in  Dulbecco's  PBS, pH  7.0, 
supplemented with 0.5% BSA were incubated with the radiolabeled ligand in a 
total volume of 250 #1 at the desired temperature  for the desired period. The 
reaction  was terminated  by the  addition  of 1 ml  of cold  PBS. Nonspecific 
binding was determined  in the presence of a  100-fold excess unlabeled ligand. 
The nonspecific binding was subtracted from total binding, and the result was 
expressed as specific binding. The tubes were centrifuged in a microcentrifuge 
for 10 s. The pellets were washed twice with 1 ml of cold PBS. The washed cell 
pellets and the combined supernates were counted for the radioactivities. 
Separation of Surface-bound and Internalized Ligand 
This was done by acetic acid dissociation of surface-bound ligand according to 
the method of Haigler et al. (7). Briefly, after incubation  with the ligand, cells 
were washed three times in PBS and incubated for 6 min at 4"C with 0.7 ml of 
equal proportions  of 0.2 M acetic acid and 0.5 M NaCI (pH 2.5). The cells 
were then centrifuged in a microcentrifuge, and the supernate  was collected. 
The cells were further incubated  for another 6 rain with 0.4 ml of the same 
acid solution, further centrifuged, and the supernate  was again collected. The 
combined  supernates  were counted  to determine  the  surface-bound  ligand, 
while the cell pellet was counted after lysis with  1 N NaOH to determine  the 
internalized ligand. 
Results 
The Binding and Uptake of ~25I-CP by Liver 
Cell Fractions 
Incubation of liver cell fractions with t25I-CP at 4"C led to the 
binding of CP  only by the endothelium.  Hepatocytes  and 
Kupffer cells did not bind t2sI-CP significantly at 4"C (Fig.  1). 
The binding of the endothelium fraction was ligand concen- 
tration-dependent, and from the Scatchard analysis (17), the 
maximum  binding was calculated to be ~347  fmol per  106 
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Figure 1. The binding of ~251-CP to endothelium, Kupffer cell,  and 
hepatocyte fractions of the liver cell suspension. Cells in each fraction 
(1  x  106) were  incubated  at  4°C  for  60  rain  with  an  increasing 
concentration of ~251-CP in 250 #1 (total volume) of Dulbecco's PBS 
that  contained  0.5%  BSA.  Inhibition was done  in  the  presence of 
100-fold  excess (4  mg/ml) of unlabeled  CP.  Specific  binding was 
calculated  by  subtracting nonspecific  binding  from  total  binding. 
Inset shows a  Scatchard plot constructed from the specific binding 
data for the endothelium. Minimal binding was noted by hepatocytes 
and  Kupffer  cells  and  can  be  explained  by  contamination  with 
endothelial cells. 
Tavassoli et al. Transcylosis  of  Ceruloplasmin  1299 cells with  dissociation constant  (Kd)  of  1  X  10 -7  M.  The 
number of receptors per cell was 2.1  x  105. The specificity of 
the binding of ;25I-CP was demonstrated by inhibition in the 
presence  of a  100-fold  excess  (4  mg/ml)  native  CP.  The 
magnitude of specific binding of J2sI-CP was a function of cell 
number (Fig. 2). 
Specific binding of t25I-CP to the endothelium as a function 
of time is shown in Fig. 3. At 4"C the binding was saturable, 
reaching a steady-state level between 5 and 30 min (data not 
shown). At 37"C (Fig. 3), however, the maximum uptake by 
endothelium  occurred after  15  min.  This was  considerably 
higher than the binding plateau at 4"C (135  ng vs 35 ng per 
60  / 
5O 
4o 
m  3o" 
2o 
o  0.5  l,o  ,,5  z.o 
Naof cells (xlO  e) 
Figure 2. Effect of cell number on the specific binding of ;2sI-CP to 
the endothelial-rich fraction.  Variable numbers of endothelial cells 
(0.5-2.0  X  10  6 cells per 250 ul) were incubated with 10 t~g of t25I-CP 
for 60  rain at 4"C. Specific binding was calculated as before.  The 
binding is a linear function of the cell number. 
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Figure 3. Uptake of ~251-CP to endothelium fraction at 37"C. Cells (1 
x  106) were incubated with  10/zg of t25I-CP at 37"C  for indicated 
periods in a final volume of 250 ul. The reaction was terminated by 
the addition of 1 ml of cold PBS after the desired period. Inhibition 
was done in the presence of unlabeled CP (4 mg/ml). Specific uptake 
is shown  as a function of time. Total uptake reaches a peak within 
15  rain and then appears to decline somewhat,  which suggests the 
release of the label at a rate higher than that of uptake. Separation of 
radioactivity into surface-bound and internalized fractions was done 
as described in the text.  The internalized fraction reaches  a  peak 
within  15  min and then begins to decline in a curve that parallels 
that of total uptake. The surface bound fraction reaches a peak within 
5  min and then  slightly declines,  which  suggests that some down 
regulation might have occurred. 
106  cells).  Cell-associated radioactivity somewhat  declined 
thereafter, which  suggests the  release of the label from  the 
ceils at a rate exceeding that of its uptake. To assure that this 
decline  was  not  the  result  of degradation  of CP  through 
proteolysis, the proteins in  the  supernate were  precipitated 
with 20%  trichloroacetic acid (TCA), and the precipitant as 
well as the supernate were counted for their radioactivity. At 
no time did the TCA nonprecipitable (soluble) radioactivity 
exceed 3%  of total radioactivity, which suggests the absence 
of significant CP degradation. Moreover, the supernate was 
subjected to column chromatography on either Sephadex G- 
25  or G-200.  The  radioactivity remained  in  a  single peak 
corresponding to that of CP. Cell viability at the end of the 
90-min incubation was unchanged.  Dissociation of total li- 
gand  uptake into  surface-bound and  internalized compart- 
ments is also shown  in Fig. 3.  The internalized ligand as a 
function  of time followed a  curve parallel to total uptake, 
reaching a  maximum after 15  min and somewhat declining 
thereafter. Surface-bound ligand, on the other hand, reached 
a  maximum  within  5  min  and  remained  stable  or  even 
declined slightly. 
Further  evidence  for  binding  and  release  of  I25I-CP  by 
endothelium was demonstrated in  an  experiment in which 
endothelium was first incubated with labeled ligand at 4"C 
for 30 rain. Cells were then washed and transferred to 37"C 
for various periods. After completion of incubation, cells were 
centrifuged and radioactivity was counted in both cells and 
the supernate. Cell-bound radioactivity, which after incuba- 
tion at 4"C  had  reached the same  magnitude as in  Fig.  1, 
began to decline as a  function of time after the transfer of 
cells to 37"C (Fig. 4). A reciprocal increase in the radioactivity 
of the supernate indicated the release of radioactivity. 
To  assure the absence of proteolysis, the proteins in  the 
supernate were precipitated with 20%  TCA and the precipi- 
tant as well as the supernate were counted for their radioac- 
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Figure 4. Endothelial cells (1  x  l0  s) were incubated with 10 ~g ~251- 
CP at 4°C for 30 min The cells were then washed three times in PBS 
and further incubated at 370C for various periods. The cell-associated 
radioactivity at time zero (surface-bound) declines  with time, and this 
decline is associated with a corresponding  increase in the radioactivity 
in the supernate. 
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radioactivity exceed 3%, which suggests the absence of signif-  _~ 
icant CP degradation. Moreover, the supernate was subjected 
to column chromatography on either Sephadex G-25 or G-  ~  3~' 
200. The radioactivity remained in a single peak correspond-  ~  o~ 
ing to that of CP.  No significant specific uptake of CP by  - 
hepatocytes or Kupffer cells was noted at 37"C either (data  ~ z~°~ 
not shown). 
IxlO  4 
The Binding Capacity of the Supernate 
Incubation of the supernate, "conditioned' by previous incu- 
bation with endothelium, with fresh target hepatocytes now 
led to the binding of the radioactive ligand in the supernate 
to cells (Fig.  5),  which  suggests  that the  radioactive ligand 
released from the endothelium  might have acquired a  new 
site recognizable by hepatocytes. This binding was not inhib- 
ited by excess unlabeled CP but was significantly inhibited by 
the galactosyl-containing molecules ASCP (Fig. 5), galactosyl- 
BSA synthesized in our laboratory (9), as well as asialofetuin 
(25). 
Desialation of CP by Endothelium 
Double-labeled  CP  (tritiated  sialic  acid,  iodinated  protein 
moiety) was incubated with endothelium fraction at 37"C for  IO0- 
various periods, and the cell-associated radioactivities were 
counted separately. The results, shown in Fig. 6, demonstrated 
that for the first 15 min the curves for both 3H and ~25I were 
overlapping, which indicated the uptake of the molecule that 
contained both labels. Thereafter, the two radioactivities dis- 
sociated  with  the  ~2sI curve  slightly  declined  in  a  pattern 
similar to Fig. 3, while the 3H curve remained stable or even  =o 
slightly increased. The data provided evidence for desializa-  ~- 50- 
tion of CP molecule by the endothelium,  c 
Mixed Cell Experiments 
The results described above suggested that CP is removed by 
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Figure 5.  Binding  of endothelium-conditioned  supernate  to  fresh 
target hepatocytes. ~25I-CP ( 10 #g) was first incubated with endothelial 
cells (1 x  106) for 90 min at 37"C in serum-free Duibecco's PBS. The 
reaction was then terminated by the addition of 150 #1 of cold PBS. 
The endothelium-conditioned supernate was then obtained by cen- 
trifugation, and its protein concentration was determined by calcu- 
lation from the radioactivity. Fresh target hepatocytes (1  x  106 in 
PBS) were incubated with increasing concentration of the putative 
ligand for 60 min at 4"C in a final volume of 250 #1. Inhibition studies 
were done in the presence of unlabeled CP (4 mg/ml) or ASCP (4 
mg/ml). The putative ligand binds to the hepatocyte fraction and the 
binding is partially inhibitable with ASCP but not with CP. 
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Figure 6. CP was double-labeled  with 3H (sialic acid residues) and ~2~I 
(protein moiety) as described in the text. This preparation (10 pg) 
was incubated with endothelium fraction ( I x  106)  at 37"C for various 
time: The two radioactivities were counted  separately.  During the 
first  15 min the two curves are overlapping and suggest the uptake of 
sialated  molecule.  Then  the  two  curves dissociate  with  3H  being 
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Figure  7. Cell-associated '25I-CP in endothelium and hepatocytes in 
mixed cell system. A mixture of endothelium and hepatocytes frac- 
tions ( l x  l06 cells each) were incubated with 40 #g/ml of ~25I-CP for 
the indicated periods at 37"C in a total volume of 250 pl of Dulbecco's 
PBS that  contained 0.5%  BSA.  Cells were then  refractionated by 
centrifugation on 15% metrizamide solution. The endothelium frac- 
tion was recovered on the interface of metrizamide and buffer and 
the hepatocyte fraction from the bottom of the tube.  Radioactivity 
and the cell number were determined. Specific uptake was calculated 
by subtracting the uptake in the presence of CP from total uptake. 
The decline in the radioactivity in the endothelium is associated with 
a reciprocal uptake of hepatocyte fraction. 
endothelium and then released only to be taken up by hepa- 
tocytes (i.e.,  the endothelium mediates the uptake of CP by 
hepatocytes). To further evaluate this, mixtures of endothe- 
lium and hepatocytes in equal ratios (1 x  106 cells each) were 
incubated at 37"C with the radiolabeled CP for various periods 
of time. The mixture was then refractionated, and the cell- 
associated radioactivity was counted separately for each frac- 
tion. The results are shown in Figs. 7 and 8. It will be noted 
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Figure 8. ~251-CP  uptake in mixed cell system. Inhibition studies were 
done in the presence of galactose-BSA (4 mg/ml) or unlabeled CP (4 
mg/ml). Experimental conditions were described in Fig. 7. The uptake 
by hepatocytes, but not by endothelium, is inhibitable by galactose- 
BSA. CP inhibits the uptake by both hepatocytes and endothelium, 
which suggests that the initial endothelial uptake is necessary for the 
subsequent hepatocyte uptake. 
that the ligand rapidly bound to the endothelium but gradu- 
ally dissociated from this fraction. During the same period, 
there was a reciprocal increase in the hepatocyte-associated 
ligand (Fig. 7). Both the initial radioactivity associated with 
endothelium and the subsequent hepatocyte-associated radio- 
activity were inhibitable with excess native CP, indicating that 
the initial association with endothelium was necessary for the 
subsequent association with hepatocytes. However, its subse- 
quent association with hepatocytes, but not the initial associ- 
ation with the endothelium, was partially inhibitable by gal- 
actose-BSA (Fig. 8). 
Discussion 
The  results  presented  here  indicate  that  in  the  liver  cell 
suspensions, CP uptake is limited to endothelial cells that are 
endowed with appropriate specific membrane receptors. Hep- 
atocytes and Kupffer cells do not take up CP significantly, 
and the small amount of binding observed could be explained 
by contamination with a small number of endothelial cells. 
This is consistent with our previous observation using a visual 
minibead probe (8). The endothelial binding of CP is further 
evident by the observation that binding is a linear function of 
endothelial cell number. That only a fraction of CP present 
in the medium is taken up by the cells may be due to down 
regulation of  receptor as a consequence of  continued exposure 
to the ligand (25).  It is also possible  that the receptor and 
ligand is transported in a complex form by the endothelium 
precluding  receptor  recycling.  This  area  deserves  further 
study. 
By fractionating the ligand taken up by cells into surface- 
bound and internalized fractions, we have further confirmed 
that the protein is indeed internalized by endothelial cells. 
This also confirms our previous observations using the mini- 
bead  probe.  In  addition,  we  have  demonstrated  that  the 
internalized ligand is then released by the endothelium into 
the medium, probably through a process of transcytosis. We 
have obtained confirmatory evidence for transcytosis of CP 
(10) by in situ perfusion of liver with colloidal gold-labeled 
CP.  The label  binds  to the  luminal  surface of liver sinus 
endothelium at 4"C and is internalized at 37"C. Morphometric 
studies indicate that the probes then move via a  vesicular 
transport system and are externalized on the abluminal side. 
During this process, the endothelium appears to desialate the 
molecule. This is suggested by dissociation of 3H and 125I after 
incubation  with  the  endothelium  in  those  experiments in 
which  sialic  acid  residues were labeled with  3H  while  the 
protein part of  the molecule was iodinated. Additional support 
for desialation of  the molecule was obtained by electrophoresis 
of the  supernate,  which  demonstrates the  generation of a 
radioactive band co-migrating with ASCP. This evidence has 
been presented elsewhere (25).  Desialation  can expose the 
penultimate  galactosyl  residues  of the  glycoprotein.  Since 
hepatocyte membrane is known to possess specific receptors 
for galactosyl termini ofglycoproteins,  the release ofdesialated 
glycoprotein can lead to its binding and uptake by hepato- 
cytes. Thus, the endothelium-conditioned molecule acquires 
the capacity to bind to fresh target hepatocytes as we have 
demonstrated here. 
That the galactosyl receptors of hepatocyte membrane may 
be involved in the binding ofendothelium--conditioned mol- 
ecules is  suggested  by the  lack  of inhibition of hepatocyte 
binding with excess native CP, but the presence of inhibition 
with  galactosyl-terminating molecules (ASCP,  asialofetuin, 
galactosyl-BSA). 
Incubation of radioactive ligand with a mixture of endothe- 
lial cells and hepatocytes indicated that the endothelial cell 
processing of the ligand may be necessary for its uptake by 
hepatocytes: cell-associated  radioactivity rapidly increased in 
the endothelial cell fraction and this was followed b~y a slow 
drop and a reciprocal slow increase in the hepatocyte fraction. 
Moreover, in this system, the uptake of ligand by both frac- 
tions was inhibited in the presence of excess unlabeled CP, 
whereas the uptake of endothelium-processed CP by hepato- 
cyte was not. 
Our work, therefore, suggests a physiological function for 
galactosyl  receptors of hepatocyte membrane. These studies 
further emphasize the function of endothelial barrier in the 
uptake of proteins. Similar endothelial transcytosis has been 
reported for another plasma protein, low density lipoprotein, 
in aorta (28), for lactoferrin in the liver (13), and by our own 
group for transferrin in the bone marrow (20). We have also 
observed endothelial mediation of transport in the liver for 
three other plasma proteins thus far studied: insulin, transfer- 
rin, and transcobalamin II (19, 21,  22). This mode of tissue 
uptake of plasma proteins may, therefore, be a general phe- 
nomenon and, if so, galactosyl receptors of hepatocytes could 
be considered as universal acceptor for many glycoproteins. 
Further support for this view is provided by the work of 
The Journal of Cell Biology,  Volume 102, 1986  1302 Regoeczi  et al.  (15,  16) who have used infusion of human 
asialotransferrin  type 3 in vivo as well as binding studies in 
vitro with purified rat liver plasma membrane. They demon- 
strated  that while the liver uptake of asialotransferrin  is via 
galactosyl receptors,  competition with native protein can re- 
duce  the  half-life  of the  ligand,  which  suggests  that  both 
receptors for native glycoprotein and asialoglycoprotein are 
needed for the uptake. They then concluded that diacytosis 
of asialotransferrin  could explain their data. 
Modification of the ligand,  as  suggested by our work,  is 
further in line with the work of Greenspan and St. Clair (6) 
who have described the modification of low density lipopro- 
tein  during  its  passage  through  the  skin  fibroblasts.  This 
process, called retroendocytosis, is very similar to modifica- 
tion of CP during its transcytosis across liver endothelium as 
described  here.  Thus,  cellular modification  of proteins  for 
subsequent use may have other examples in cell biology. 
This work was supported by National Institutes of Health grant AM- 
30142 to M. Tavassoli. 
Received  for publication  25  October  1985,  and  in  revised  form  6 
December  1985. 
References 
1.  Aisen, P.,A.G. Morell, A.Alpert, andI. Sternlieb. 1964. Biliaryexcretion 
of ceruloplasmin copper. Nature (Lond.).  203:873-874. 
2.  Ashwell, G., and A. G. Morell. 1974. The role of surface carbohydrates 
in  the  hepatic  recognition  and  transport of circulating  glycoproteins.  Adv. 
Enzymol. 41:99-128. 
3.  Bolton, A. E., and W. M. Hunter.  1973. The labeling of proteins to high 
specific  radioactivities  by  conjugation  to  a  ~2SI-containing acylating  agent. 
Biochem.  J.  133:529-538. 
4.  David, G. S.  1972. Solid state lactoperoxidase: a highly stable enzyme 
for simple, gentle iodination  of proteins.  Biochem.  Biophys.  Res.  Commun. 
48:464-471. 
5.  Dyer,  J.  R.  1956. Periodate  oxidations  in  biochemical  analysis.  In 
Methods  of Biochemical Analysis. Volume  111. Interscience Publishers,  Inc., 
New York.  111-152. 
6.  Greenspan,  P.,  and  R.  W.  St.  Clair. 1984. Retroendocytosis  of low 
density lipoprotein. Z Biol. Chem. 259:1703-1713. 
7.  Haigler, H. T., F. R. Maxfield, M. C. Willingham, and I. Pastan.  1980. 
Dansylcardaverine  inhibits  internalization  of ~251-epidermal growth factor in 
BALB 3T3 cells. J. Biol. Chem. 255:1239-1241. 
8.  Kataoka,  M., and M. Tavassoli. 1984. Ceruloplasmin  receptors in liver 
cell suspensions are limited to the endothelium.  Exp. Cell Res. 155:232-240. 
9.  Kataoka, M., and M. Tavassoli. 1984. Synthetic neoglycoproteins: a class 
of reagent for detection  of sugar-recognizing substances. J. Histochem. Cyto- 
chem. 32:1091-1098. 
10.  Kataoka, M., and M. Tavassoli. 1985. The role of liver endothelium  in 
the binding and uptake of ceruloplasmin: studies with colloidal gold probes. Z 
Ultrastruct. Res. 90:194-202. 
I1.  Kishimoto,  T., and M. Tavassoli. 1986. Double-labeling of transferrin: 
tritium  labeling of sialic acid and t25I or SgFe labeling of the protein  moiety. 
Anal.  Biochern. In press. 
12.  Kolb-Baekofen, V. 1981. Hepatic receptor for asialoglycoproteins. Ultra- 
structural  demonstration  of ligand-induced  microaggregation  of receptors. 
Biochim.  Biophys.  Acta. 645:293-299. 
13.  Moguilevsky, M., L. A. Retegui, P. J. Courtoy, C. E. Castracane, and P. 
L. Masson. 1984. Lab. Invest.  50:335-340. 
14.  Morell, A. G.,  G. Gregoriadis,  I. S.  Scheinberg, J.  Hickman,  and G. 
Ashwell. 1971. The role of sialic acid in determining  the survival of glycopro- 
reins in the circulation. J. Biol. Chem. 246:1461-1467. 
15.  Regoeczi, E., P. A. Chindemi,  M. T. Debanne,  and M. W. C. Hutton. 
1982. Dual nature of hepatic lectin pathway for human asialotransferrin type 
3 in the rat. J. Biol. Chem. 257:5431-5436. 
16.  Regoeczi, E., and A. Koj.  1985. Diacytosis of human asialotransferrin 
type 3 in the rat  liver is due to the sequential  engagement of two receptors. 
Exp. Cell Res. 160:1-8. 
17.  Scatchard, G.  1949. The attractions of proteins for small molecules and 
ions. Ann. NY Acad. Sci.  51:660-672. 
18.  Seglen, P. O.  1976. Preparation  of isolated rat liver cells. Methods Cell 
Biol. 8:29-83. 
19.  Soda, R., and M. Tavassoli.  1983. Distribution  of insulin receptors in 
liver cell suspension using a minibead probe. Highest density is on endothelial 
cell. Exp. Cell Res. 145:389-395. 
20.  Soda, R., and M. Tavassoli.  1984. Transendothelial  transport of iron- 
transferrin complex in the bone marrow. J. Ultrastruct. Res. 88:18-29. 
21.  Soda, R., and M. Tavassoli. 1984. Liver endothelium and not hepatocyte 
or Kupffer cells have transferrin receptors. Blood. 63:270-276. 
22.  Soda, R., M. Tavassoli, and D. W. Jacobsen.  1985. Endothelial uptake 
and release of transcobalamin  II in liver cell suspensions. Blood. 65:795-802. 
23.  Stel, H. V., T. H. van der Kwart, and E. C. I. Veerman.  1983. Detection 
of  factor Vlll/coagulant  antigen in human liver tissue. Nature (Lond.). 303:530- 
532. 
24.  Takahashi,  K., and M. Tavassoli.  1981. A minibead  method to study 
cell surface receptors for various proteins coupled to latex particles. J.  Ultras- 
truct. Res. 75:205-217. 
25.  Tavassoli, M.  1986. Liver endothelium  binds, transports and desialates 
ceruloplasmin which is then recognized by galactosyl receptors of hepatocytes. 
Trans. Assoc. Am. Phys. In press. 
26.  Uchida, Y., U. Tsukada, and T. Sugimori. 1977. Distribution  of neura- 
minidase  in arthrobacter  and its purification  by affinity chromatography.  J. 
Biochem.  82:1425-1433. 
27.  Van  Lenten,  L., and G.  Ashwell. 1971. Studies on the  chemical  and 
enzymatic  modification  of glycoproteins: a  general  method  for tritiation  of 
sialic acid-containing glycoprotein. J. Biol. Chem. 246:1889-1894. 
28.  Vasile, E., M. Simionesco, and N. Simioneseo.  1983. Visualization of 
the binding,  endocytosis, and transcytosis  of low-density lipoprotein  in the 
arterial endothelium  in situ. J. Cell Biol. 96:1677-1689. 
29.  Young, S. P., A. Bomford, and R. Williams. 1983. Dual pathway for the 
uptake  of rat  asialotransferrin  by rat  hepatocytes. J. Biol.  Chem.  258:4972- 
4976. 
30.  Zahlten,  R.  N.,  H.  K.  Hagler, M.  E.  Nejtek,  and  C.  J.  Day.  1978. 
Morphological characterization  of Kupffer  and endothelial  cells of rat  liver 
isolated by counter flow elutriation. Gastroenterol. 75:80-87. 
Tavassoli et al. Transcytosis  of Ceruloplasmin  1303 